Cargando…

ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses

Cytosolic double-stranded RNA (dsRNA) initiates type I IFN responses. Endogenous retroelements, notably Alu elements, constitute a source of dsRNA. Adenosine-to-inosine (A-to-I) editing by ADAR induces mismatches in dsRNA and prevents recognition by MDA5 and autoinflammation. To identify additional...

Descripción completa

Detalles Bibliográficos
Autores principales: Herzner, Anna-Maria, Khan, Zia, Van Nostrand, Eric L., Chan, Sara, Cuellar, Trinna, Chen, Ronald, Pechuan-Jorge, Ximo, Komuves, Laszlo, Solon, Margaret, Modrusan, Zora, Haley, Benjamin, Yeo, Gene W., Behrens, Timothy W., Albert, Matthew L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313407/
https://www.ncbi.nlm.nih.gov/pubmed/34297039
http://dx.doi.org/10.1084/jem.20201833
_version_ 1783729340854304768
author Herzner, Anna-Maria
Khan, Zia
Van Nostrand, Eric L.
Chan, Sara
Cuellar, Trinna
Chen, Ronald
Pechuan-Jorge, Ximo
Komuves, Laszlo
Solon, Margaret
Modrusan, Zora
Haley, Benjamin
Yeo, Gene W.
Behrens, Timothy W.
Albert, Matthew L.
author_facet Herzner, Anna-Maria
Khan, Zia
Van Nostrand, Eric L.
Chan, Sara
Cuellar, Trinna
Chen, Ronald
Pechuan-Jorge, Ximo
Komuves, Laszlo
Solon, Margaret
Modrusan, Zora
Haley, Benjamin
Yeo, Gene W.
Behrens, Timothy W.
Albert, Matthew L.
author_sort Herzner, Anna-Maria
collection PubMed
description Cytosolic double-stranded RNA (dsRNA) initiates type I IFN responses. Endogenous retroelements, notably Alu elements, constitute a source of dsRNA. Adenosine-to-inosine (A-to-I) editing by ADAR induces mismatches in dsRNA and prevents recognition by MDA5 and autoinflammation. To identify additional endogenous dsRNA checkpoints, we conducted a candidate screen in THP-1 monocytes and found that hnRNPC and ADAR deficiency resulted in synergistic induction of MDA5-dependent IFN responses. RNA-seq analysis demonstrated dysregulation of Alu-containing introns in hnRNPC-deficient cells via utilization of unmasked cryptic splice sites, including introns containing ADAR-dependent A-to-I editing clusters. These putative MDA5 ligands showed reduced editing in the absence of ADAR, providing a plausible mechanism for the combined effects of hnRNPC and ADAR. This study contributes to our understanding of the control of repetitive element–induced autoinflammation and suggests that patients with hnRNPC-mutated tumors might maximally benefit from ADAR inhibition-based immunotherapy.
format Online
Article
Text
id pubmed-8313407
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-83134072021-08-05 ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses Herzner, Anna-Maria Khan, Zia Van Nostrand, Eric L. Chan, Sara Cuellar, Trinna Chen, Ronald Pechuan-Jorge, Ximo Komuves, Laszlo Solon, Margaret Modrusan, Zora Haley, Benjamin Yeo, Gene W. Behrens, Timothy W. Albert, Matthew L. J Exp Med Article Cytosolic double-stranded RNA (dsRNA) initiates type I IFN responses. Endogenous retroelements, notably Alu elements, constitute a source of dsRNA. Adenosine-to-inosine (A-to-I) editing by ADAR induces mismatches in dsRNA and prevents recognition by MDA5 and autoinflammation. To identify additional endogenous dsRNA checkpoints, we conducted a candidate screen in THP-1 monocytes and found that hnRNPC and ADAR deficiency resulted in synergistic induction of MDA5-dependent IFN responses. RNA-seq analysis demonstrated dysregulation of Alu-containing introns in hnRNPC-deficient cells via utilization of unmasked cryptic splice sites, including introns containing ADAR-dependent A-to-I editing clusters. These putative MDA5 ligands showed reduced editing in the absence of ADAR, providing a plausible mechanism for the combined effects of hnRNPC and ADAR. This study contributes to our understanding of the control of repetitive element–induced autoinflammation and suggests that patients with hnRNPC-mutated tumors might maximally benefit from ADAR inhibition-based immunotherapy. Rockefeller University Press 2021-07-23 /pmc/articles/PMC8313407/ /pubmed/34297039 http://dx.doi.org/10.1084/jem.20201833 Text en © 2021 Genentech, Inc. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Herzner, Anna-Maria
Khan, Zia
Van Nostrand, Eric L.
Chan, Sara
Cuellar, Trinna
Chen, Ronald
Pechuan-Jorge, Ximo
Komuves, Laszlo
Solon, Margaret
Modrusan, Zora
Haley, Benjamin
Yeo, Gene W.
Behrens, Timothy W.
Albert, Matthew L.
ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses
title ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses
title_full ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses
title_fullStr ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses
title_full_unstemmed ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses
title_short ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses
title_sort adar and hnrnpc deficiency synergize in activating endogenous dsrna-induced type i ifn responses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313407/
https://www.ncbi.nlm.nih.gov/pubmed/34297039
http://dx.doi.org/10.1084/jem.20201833
work_keys_str_mv AT herznerannamaria adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT khanzia adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT vannostrandericl adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT chansara adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT cuellartrinna adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT chenronald adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT pechuanjorgeximo adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT komuveslaszlo adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT solonmargaret adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT modrusanzora adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT haleybenjamin adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT yeogenew adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT behrenstimothyw adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses
AT albertmatthewl adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses